Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series
Publication Date
2024
Content Type
Article
PubMed ID:
Citation
Frontiers in Oncology (2024) 14:1419246
2024
Article
Frontiers in Oncology (2024) 14:1419246